Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Similar articles for PubMed (Select 23858048)

1.

Expression of methotrexate transporters and metabolizing enzymes in rheumatoid synovial tissue.

Stamp LK, Hazlett J, Highton J, Hessian PA.

J Rheumatol. 2013 Sep;40(9):1519-22. doi: 10.3899/jrheum.130066. Epub 2013 Jul 15.

PMID:
23858048
2.

Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide.

van der Heijden JW, Oerlemans R, Tak PP, Assaraf YG, Kraan MC, Scheffer GL, van der Laken CJ, Lems WF, Scheper RJ, Dijkmans BA, Jansen G.

Arthritis Rheum. 2009 Mar;60(3):669-77. doi: 10.1002/art.24354.

3.

Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism.

Bohanec Grabar P, Logar D, Lestan B, Dolzan V.

Eur J Clin Pharmacol. 2008 Nov;64(11):1057-68. doi: 10.1007/s00228-008-0521-7. Epub 2008 Jul 8.

PMID:
18607581
4.

Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis.

Ranganathan P, Culverhouse R, Marsh S, Mody A, Scott-Horton TJ, Brasington R, Joseph A, Reddy V, Eisen S, McLeod HL.

J Rheumatol. 2008 Apr;35(4):572-9. Epub 2008 Mar 15.

PMID:
18381794
5.

Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis.

Blits M, Jansen G, Assaraf YG, van de Wiel MA, Lems WF, Nurmohamed MT, van Schaardenburg D, Voskuyl AE, Wolbink GJ, Vosslamber S, Verweij CL.

Arthritis Rheum. 2013 Nov;65(11):2791-802. doi: 10.1002/art.38094.

6.

Adenosine receptor expression in rheumatoid synovium: a basis for methotrexate action.

Stamp LK, Hazlett J, Roberts RL, Frampton C, Highton J, Hessian PA.

Arthritis Res Ther. 2012 Jun 8;14(3):R138. doi: 10.1186/ar3871.

7.

Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium.

Ducreux J, Durez P, Galant C, Nzeusseu Toukap A, Van den Eynde B, Houssiau FA, Lauwerys BR.

Arthritis Rheumatol. 2014 Jan;66(1):15-23. doi: 10.1002/art.38202.

PMID:
24449571
8.

Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients.

van der Straaten RJ, Wessels JA, de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Allaart CF, Bogaartz J, Tiller M, Huizinga TW, Guchelaar HJ.

Pharmacogenomics. 2007 Feb;8(2):141-50.

PMID:
17286537
9.

ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients.

Takatori R, Takahashi KA, Tokunaga D, Hojo T, Fujioka M, Asano T, Hirata T, Kawahito Y, Satomi Y, Nishino H, Tanaka T, Hirota Y, Kubo T.

Clin Exp Rheumatol. 2006 Sep-Oct;24(5):546-54.

PMID:
17181924
10.

Association of MDR1 C3435T and RFC1 G80A polymorphisms with methotrexate toxicity and response in Jordanian rheumatoid arthritis patients.

Samara SA, Irshaid YM, Mustafa KN.

Int J Clin Pharmacol Ther. 2014 Sep;52(9):746-55. doi: 10.5414/CP202098.

PMID:
25074866
12.

Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.

Bramlage CP, Kaps C, Ungethüm U, Bramlage P, Koziolek M, Wessels J, Krenn V, Pruss A, Müller GA, Strutz F, Burmester GR, Häupl T.

Scand J Rheumatol. 2008 Nov-Dec;37(6):401-9. doi: 10.1080/03009740802120010.

PMID:
18830904
13.

2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.

Berkun Y, Abou Atta I, Rubinow A, Orbach H, Levartovsky D, Aamar S, Arbel O, Dresner-Pollak R, Friedman G, Ben-Yehuda A.

J Rheumatol. 2007 Aug;34(8):1664-9. Epub 2007 Jul 1.

PMID:
17611986
15.

Association of the TYMS 3G/3G genotype with poor response and GGH 354GG genotype with the bone marrow toxicity of the methotrexate in RA patients.

Jekic B, Lukovic L, Bunjevacki V, Milic V, Novakovic I, Damnjanovic T, Milasin J, Popovic B, Maksimovic N, Damjanov N, Radunovic G, Kovacevic L, Krajinovic M.

Eur J Clin Pharmacol. 2013 Mar;69(3):377-83. doi: 10.1007/s00228-012-1341-3. Epub 2012 Jul 5.

PMID:
22763757
16.

Molecular basis for pharmacokinetics and pharmacodynamics of methotrexate in rheumatoid arthritis therapy.

Inoue K, Yuasa H.

Drug Metab Pharmacokinet. 2014;29(1):12-9. Epub 2013 Nov 26. Review.

17.

Methotrexate and cyclooxygenase metabolism in cultured human rheumatoid synoviocytes.

Vergne P, Liagre B, Bertin P, Cook-Moreau J, Treves R, Beneytout JL, Rigaud M.

J Rheumatol. 1998 Mar;25(3):433-40.

PMID:
9517759
18.

Contribution of common polymorphisms in reduced folate carrier and gamma-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis.

Dervieux T, Kremer J, Lein DO, Capps R, Barham R, Meyer G, Smith K, Caldwell J, Furst DE.

Pharmacogenetics. 2004 Nov;14(11):733-9.

PMID:
15564880
19.
20.

Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in United States veterans with rheumatoid arthritis.

Davis LA, Polk B, Mann A, Wolff RK, Kerr GS, Reimold AM, Cannon GW, Mikuls TR, Caplan L.

Clin Exp Rheumatol. 2014 May-Jun;32(3):324-32. Epub 2014 Jan 20.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk